PGEN

PRECIGEN, INC.

Tremor tracks 3 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

5 insiders sold shares within a monthSince May 28, 2026+1.5

Trials

PGENPrecigen, Inc
12Calm
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
Running, no new patientsPhase 1/238 patientsMain results: Jun 5, 2024
PGENPrecigen, Inc
2Calm
Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children
Not started yetPhase 315 patientsMain results: Jan 2029
PGENPrecigen, Inc
2Calm
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Signing up patientsPhase 224 patientsMain results: Nov 11, 2026

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

16 sales (6 not pre-planned) · 1 purchase

KINDLER JEFFREY BBoard member · Aug 26, 2026Sold 185,000 sharesabout $1.4 million · not pre-planned
Shah Rutul RChief Operating Officer · Aug 25, 2026Sold 15,342 sharesabout $115 thousand · pre-planned
Tennant PhilChief Commercial Officer · Aug 25, 2026Sold 79,166 sharesabout $594 thousand · pre-planned
AGEE NANCY HBoard member · Aug 21, 2026Bought 3,411 sharesabout $25 thousand ·
Shah Rutul RChief Operating Officer · Aug 21, 2026Sold 34,658 sharesabout $260 thousand · pre-planned
Shah Rutul RChief Operating Officer · Aug 6, 2026

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.